Hims & Hers Health stories

Aug 10, 2026

Hims & Hers posts wider loss as shift to branded weight-loss drugs drives up costs

Hims & Hers Health reported a wider-than-expected second-quarter loss as the telehealth company's shift to branded weight-loss drugs drove up costs, sending shares down 6% in extended trading. The company plans to enter the peptides market before year-end.

Aug 10, 20263 sources

Jul 29, 2026

FTC sues Hims & Hers over sharing users' health information with advertisers

The Federal Trade Commission, Utah, and Los Angeles County sued telehealth company Hims & Hers Health for allegedly misleading consumers about its products and sharing private health information with advertisers. Shares fell 10% following the announcement.

Jul 29, 20262 sources